73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Survivorship portal brings cancer researchers one click away from discovery

Survivorship portal brings cancer researchers one click away from discovery

bySt. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainScientists from St. Jude Children's Research Hospital today announced the St. Judesurvivorship portal—the fi

Survivorship portal brings cancer researchers one click away from discovery

bySt. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainScientists from St. Jude Children's Research Hospital today announced the St. Judesurvivorship portal—the fi
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
Researchers uncover novel aspect of tumor evolution and potential targets for therapy

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s

Researchers uncover novel aspect of tumor evolution and potential targets for therapy

by Ludwig Institute for Cancer ResearchGraphical abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/j.cmet.2022.12.003A Ludwig Cancer Research study has discovered that the immune s
Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati

Re-engineered, blue light-activated immune cells penetrate and kill solid tumors

byPennsylvania State UniversityMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteImmunotherapies that mobilize a pati
Promising new treatment for deadly pediatric tumors

Promising new treatment for deadly pediatric tumors

by Konstanze Adam, Wilhelm Sander-StiftungA simplified schematic of the DNA damage repair pathways. Below there is the curves showing cell viability in response to the ATR inhibitors (AZD6738 and BAY

Promising new treatment for deadly pediatric tumors

by Konstanze Adam, Wilhelm Sander-StiftungA simplified schematic of the DNA damage repair pathways. Below there is the curves showing cell viability in response to the ATR inhibitors (AZD6738 and BAY
Mobile app gives cancer patients better quality of life

Mobile app gives cancer patients better quality of life

by CORDISCredit: AI-generated imageAlthough comprising only one eighth of the global population, Europe has a quarter of the total number of cancer cases worldwide. Each year, there are around 3.

Mobile app gives cancer patients better quality of life

by CORDISCredit: AI-generated imageAlthough comprising only one eighth of the global population, Europe has a quarter of the total number of cancer cases worldwide. Each year, there are around 3.
Mechanism identified for drug resistance in glioblastoma brain tumors

Mechanism identified for drug resistance in glioblastoma brain tumors

by Sarah Avery,Duke UniversityPro-tumor immune programming in the glioma microenvironment is CaMKK2 dependent. a Schematic depicting scRNA-seq experimental design. n = 4 WT and CaMKK2 KO mice ha

Mechanism identified for drug resistance in glioblastoma brain tumors

by Sarah Avery,Duke UniversityPro-tumor immune programming in the glioma microenvironment is CaMKK2 dependent. a Schematic depicting scRNA-seq experimental design. n = 4 WT and CaMKK2 KO mice ha
Treating tumors with engineered dendritic cells

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center

Treating tumors with engineered dendritic cells

by Ecole Polytechnique Federale de LausanneCerebral tumor (glioma) of a mouse. Credit: EPFL / Michele De Palma—CC-BY-SA 4.0Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center
Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing

Study: Diet, exercise improve outcomes of chemotherapy for women with breast cancer

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA new Yale Cancer Center study finds a targeted diet and exercise intervention could improve outcomes for women undergoing
T cell behavior determines which tumors respond to treatment

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne

T cell behavior determines which tumors respond to treatment

by Weill Cornell Medical CollegeCredit: CC0 Public DomainImmunotherapy unleashes the power of the immune system to fight cancer. However, for some patients, immunotherapy doesn't work, and ne
A new screening protocol can detect aggressive prostate cancers more selectively

A new screening protocol can detect aggressive prostate cancers more selectively

byTampere UniversityCredit: CC0 Public DomainProstate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.A larg

A new screening protocol can detect aggressive prostate cancers more selectively

byTampere UniversityCredit: CC0 Public DomainProstate cancer is the most common cancer in men. As a cause of men's cancer death, it ranks the second in Finland and the third in Europe.A larg
CAR-T immunotherapy could be improved to kill solid tumors

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is

CAR-T immunotherapy could be improved to kill solid tumors

by Thomas Jefferson UniversityCancer cell during cell division. Credit: National Institutes of HealthImmunotherapy, which harnesses the power of the body's immune system to fight disease, is